Everzom
Develops exosome-based therapeutics and biomanufacturing for regenerative medicine and biotech partners
Highlights
- New on EvolcAdded 2026-11-02
About Everzom
EVerZom develops exosome-based therapeutics and proprietary technologies for scalable exosome manufacturing and formulation. Its pipeline includes candidates for Crohn’s disease-related fistulas and acute-on-chronic liver failure, alongside a platform for co-development in regenerative medicine.
The company works with biotech partners, including through bioproduction and co-development. It was founded in 2019 and is headquartered in Strasbourg, France; its story identifies Paris as its founding location. The company received EIC Accelerator funding and closed a €10 million funding round in 2025.
Product: Exosome-based therapeutic candidates and a proprietary platform for exosome manufacturing and formulation.
Jobs at Everzom
Leadership
- Jeanne Volatron · CEO/CSOSource: company website
- Nicolas Rousseau · CEO/CBOSource: company website
- Noémie Escaith · CFOSource: company website
- Virginie Barthel · Head of Clinical OperationsSource: company website
More biotech & pharma companies
Fabentech
Develops antibody-based emergency treatments for governments and health organizations facing biological threatsNew on EvolcFermentalg
Microalgae-derived ingredients for nutrition, wellness and pet health companiesNew on EvolcGenclis
Biotechnology company developing RNA-derived therapeutics for drug discovery and developmentNew on EvolcGenerare Bioscience
Microbial chemistry libraries and screenable molecules for pharma and biotech drug discovery programsNew on EvolcRemote-friendlyGENOMINES
Grows nickel-accumulating plants on low-grade soils to produce battery-grade nickel for critical metal supply chainsGenoscreen
Genomics, sequencing and bioinformatics services for academic and industrial research teamsNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Content delivery
- CloudflareHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Content management
- WordPressHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
- Website resourcedeclared script/iframe or software asset
- Page markupsoftware structure signature
Frontend frameworks
- jQueryHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.